Melanoma Multidisciplinary Clinic
Collaborative care, for your patient's best outcome
At OHSU, our goal is simple: identify and execute a care plan which results in the best possible outcome for all individuals with melanoma and other skin cancers. Getting to this goal, however, can be anything but simple.
We have organized a team of specialists, all of whom have dedicated their careers to finding and eliminating cancer, to work together to combat melanoma in Oregon and beyond. The melanoma multidisciplinary clinic is a unique opportunity for patients to be able to receive consultation and treatment, all at the same location and often within the same day. We work closely with referring providers to make sure each individual patient has a transparent and effective plan.
Patients seen in the Melanoma Multidisciplinary Clinic generally include:
- Patients at high-risk for developing melanoma
- Personal/family history
- Many atypical nevi
- Genetic traits
- Immunosuppressed patients
- Patients with a suspected or diagnosed melanoma
- Patients with aggressive squamous cell carcinomas, merkel cell carcinoma, and other cutaneous malignancies
We offer a wide variety of treatment options for patients with locally advanced or metastatic disease including:
- Surgical treatment/removal
- Radiation therapy
- Targeted therapy
- Clinical Trials
Clinical research is a key element for the program, as we strive to understand and treat melanoma better. Thus, we offer our patients additional treatment options through a robust portfolio of clinical trials.
As faculty at OHSU, all clinic providers in the Melanoma Multidisciplinary Clinic have experience working with trials and research. Clinic provider Dr. Matthew Taylor is the program director for OHSU Knight Cancer Institute phase 1 clinical trials.
Learn more about active melanoma clinical trials
Members of the melanoma multi-disciplinary clinic meet weekly to discuss difficult clinical cases. These tumor boards provide invaluable feedback for providers across OHSU and beyond, leveraging cross-functional expertise to collaborate and find the best treatment plans possible.
We are currently developing a virtual platform, which will allow providers from across the state to join the melanoma tumor board meetings for the purpose of discussing cases and for continuing education in melanoma.